The treatment of brain ischemia with vasopressor drugs.
D000368:Aged; D000628:Aminophylline / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000503:physiopathology; D002560:Cerebrovascular Circulation; D003907:Dexamethasone / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008353:Mannitol / Q000627:therapeutic use; D008875:Middle Aged; D009638:Norepinephrine / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D012039:Regional Blood Flow; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D003911:Dextrans; D014662:Vasoconstrictor Agents; D000628:Aminophylline; D008353:Mannitol; D003907:Dexamethasone; D010208:Papaverine; D005947:Glucose; D009638:Norepinephrine